WINDTREE THERAPEUTICS INC /DE/ Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Windtree Therapeutics Inc /De/ quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Windtree Therapeutics Inc /De/ Return On Equity for the quarter ending June 30, 2024 was -153 %, a 28% increase year-over-year.
  • Windtree Therapeutics Inc /De/ annual Return On Equity for 2023 was -275 %, a 42.7% decline from 2022.
  • Windtree Therapeutics Inc /De/ annual Return On Equity for 2022 was -193 %, a 71.2% decline from 2021.
  • Windtree Therapeutics Inc /De/ annual Return On Equity for 2021 was -113 %, a 158% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -153 +59.5 +28% Apr 1, 2024 Jun 30, 2024
Q1 2024 -62.9 +199 +76% Jan 1, 2024 Mar 31, 2024
Q4 2023 -275 -82.3 -42.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -275 -124 -82.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -212 -84.3 -65.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -262 -117 -80.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -193 -80.2 -71.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -150 -57.9 -62.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -128 -42.5 -49.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -146 -102 -233% Jan 1, 2022 Mar 31, 2022
Q4 2021 -113 -69 -158% Oct 1, 2021 Dec 31, 2021
Q3 2021 -92.6 -49.9 -117% Jul 1, 2021 Sep 30, 2021
Q2 2021 -85.6 -42.2 -97% Apr 1, 2021 Jun 30, 2021
Q1 2021 -43.7 -0.85 -1.98% Jan 1, 2021 Mar 31, 2021
Q4 2020 -43.6 +0.5 +1.13% Oct 1, 2020 Dec 31, 2020
Q3 2020 -42.7 +5.36 +11.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -43.5 +22.2 +33.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -42.9 +83.5 +66.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -44.1 -462 -111% Oct 1, 2019 Dec 31, 2019
Q3 2019 -48.1 -80.4 -249% Jul 1, 2019 Sep 30, 2019
Q2 2019 -65.7 -101 -284% Apr 1, 2019 Jun 30, 2019
Q1 2019 -126 -173 -370% Jan 1, 2019 Mar 31, 2019
Q4 2018 418 +356 +575% Oct 1, 2018 Dec 31, 2018
Q3 2018 32.3 -56.3 -63.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 35.8 -75.3 -67.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 46.8 -101 -68.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 61.8 -158 -71.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 88.6 -406 -82.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 111 +3.9K Apr 1, 2017 Jun 30, 2017
Q1 2017 148 +1.41K Jan 1, 2017 Mar 31, 2017
Q4 2016 220 +934 Oct 1, 2016 Dec 31, 2016
Q3 2016 494 +1.03K Jul 1, 2016 Sep 30, 2016
Q2 2016 -3.79K -3.44K -1001% Apr 1, 2016 Jun 30, 2016
Q1 2016 -1.26K -1.07K -569% Jan 1, 2016 Mar 31, 2016
Q4 2015 -714 -585 -452% Oct 1, 2015 Dec 31, 2015
Q3 2015 -533 -430 -418% Jul 1, 2015 Sep 30, 2015
Q2 2015 -344 -223 -184% Apr 1, 2015 Jun 30, 2015
Q1 2015 -188 -52.1 -38.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -129 +71 +35.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -103 +223 +68.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -121 +126 +51% Apr 1, 2014 Jun 30, 2014
Q1 2014 -136 +50.1 +26.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -200 -74.6 -59.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -326 -190 -140% Jul 1, 2013 Sep 30, 2013
Q2 2013 -247 -122 -98.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -186 +3.01 +1.59% Jan 1, 2013 Mar 31, 2013
Q4 2012 -126 Oct 1, 2012 Dec 31, 2012
Q3 2012 -136 Jul 1, 2012 Sep 30, 2012
Q2 2012 -125 Apr 1, 2012 Jun 30, 2012
Q1 2012 -189 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.